Nov 29, 2025, 16:35
Deferral of Immunosuppression in Acquired Hemophilia
Andreas Tiede, Professor in the Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation at Hannover Medical School, posted on LinkedIn:
”If you’re interested in Acquired Hemophilia A, read the thoughtful comments by Jerome Teitel and Jean St.-Louis about the more careful use of immunosuppressants in these fragile patients.”
Title: Deferral of immunosuppression in acquired hemophilia
Authors: Jerome Teitel, Jean St-Louis
Stay updated with Hemostasis Today.
Acquired Hemophilia
Acquired Hemophilia A
American Society of Hematology
Andreas Tiede
ASH
bleeding disorders
Blood Journal
haemophilia
Health
Hematology
Hemophilia
Hemophilia A
Hemostasis
Hemostasis Today
Hôpital Maisonneuve-Rosemont
Immunosuppression
Jean St-Louis
Jerome Teitel
Medicine
St. Michael’s Hospital
thrombosis
Université de Montréal
University of Toronto
-
Aug 29, 2026, 17:05What If Factor XI inhibition Could Reshape the Future of Anticoagulation – ISTH
-
Aug 29, 2026, 16:44Nipocalimab for Warm Autoimmune Hemolytic Anemia: What the FDA Approval Means
-
Aug 29, 2026, 16:17The Future of Bleeding Disorder Research is Getting Bigger – Global Hemophilia Report
-
Aug 29, 2026, 16:03Marco De Giovanni: The Platelet – Serotonin Link Behind Severe COVID-19
-
Aug 29, 2026, 16:01FDA Approves Imaavy for wAIHA – Thalassaemia International Federation
-
Aug 29, 2026, 16:00Dianne E. van der Wal: Advancing Platelet Research at ISTH 2026 in Paris
-
Aug 29, 2026, 15:55Cory Dugan: Iron Deficiency and Anemia Across the Female Life
-
Aug 29, 2026, 15:53Melina Rodriguez: FDA Approves Imaavy as First Treatment for Warm AIHA
-
Aug 29, 2026, 15:50Karen T․: Seeking a Patient Liaison to Support the Bleeding Disorders Community